Hemophelia A (classic hemophelia) Flashcards
Definition
- Sex-linked recessive coagulation defect due to deficiency of factor VIII-C
- 20% of cases are new mutations.
- Hemophilia A represents 80% of all hemophiliacs
Pathophysiology
- Factor VIII-C is synthesized by the liver and reticuloendothelial system
- In plasma, factor VIII-C is stabilized and protected from degradation by Von Willebrand factor(vWF) protein
- In the presence of normal vWF, the half-life of factor VIII-C is approximately 12 hours, whereas in the absence of vWF, the half-life of factor VIII-C is reduced to 2 hours
Pattern of deficiency
- Hemostatic level of F VIII-C is >30- 40U/L (30-40%); below which bleeding occur
- Plasma level of Factor VIII-C in carrier females is between 30-50 %
Clinical picture
Severe disease→F8 <1% → bleed spontaneously
-moderate → F8 1-5% → Bleed with minor
trauma
Mild disease → 5-25% → Bleed with severe
trauma
Con the clinical picture
- In neonate Unusual bleeding from the circumcision site or umbilical stump
- External bleeding e.g.
Epistaxis
• Dental /mouth bleeding
• GIT bleeding Hematuria - Skin bleeding
• Easy bruising
• Ecchymotic patches Hematomas
• No petechaie - Hemarthrosis🌚 target joint
• The hallmark of hemophilia A and B
• Affects mainly the big joints of the lower limbs
• Affected joint become swollen, red, hot, and tender with limited mobility
• Tend to be recurrent
• Recurrent hemarthrosisp joint fibrosis / ankylosis & muscle atrophy - Internal bleeding e.g.
• Muscle hematoma Intracranial Retroperitoneal Hemothorax
-
Inv for both
PTT is prolonged 2-3 times above the normal range, whereas other
screening tests are usually normal (including PT).
Mixing study is positive.
Specific F8 or F9 assay is used to confirm the Dx.
Hemophilia carriers (e.g. other family members) can be screened by
Genetic studies or F8:VWF ratio.
Tx
Nelson
Tranexamic acid
Antifibrinolytics
- 1g loading in 10 min the 1g maintenance in 8 h
For truma in first 3 h
Complications of hemophilia
A. Due to bleeding
- Hemophilic arthropathypjoint stiffness & Muscle atrophy
- Severe intracranial hemorrhage.
- Severe blood lossp hypovolemic shock
B. Complications of transfusion (See chronic transfusion in thalassemia )
C. Complications of factor VIII therapy
- Hypersensitivity reactions
- Factor VIII inhibitors (Antibodies)
- Develop in about 5-10 %
- Hemorrhage become refractory to treatment
- Inhibitors (measured by Bethesda Units) should be screened for annually
Hemophelia B (Christmas disease)
- Factor IX deficiency.
- Incidence: 1 / 50.000(in contrast to hemophelia A which is 1 / 10.000)
- Sex-linked recessive disorder.
- As hemophelia A but milder.
- Treated by: Recombinant factor IX or factor IX concentrate given/24 hours.
- Prophylactic treatment: Recombinant factor IX twice a week.
Hemophelia C
- Factor XI deficiency.
- Autosomal recessive disorder so can affect both sexes.
- Very mild disease.
- Treated by fresh frozen plasma given / 48 hours.